These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4678968)

  • 41. Effect of long-term L-dopa administration on brain biogenic amines and behavior in the rat.
    Narotzky R; Griffith D; Stahl S; Bondareff W; Zeller EA
    Exp Neurol; 1973 Feb; 38(2):218-30. PubMed ID: 4690179
    [No Abstract]   [Full Text] [Related]  

  • 42. Narcotic withdrawal like mouse jumping produced by amphetamine and L-DOPA.
    Lal H; Colpaert FC; Laduron P
    Eur J Pharmacol; 1975 Jan; 30(1):113-6. PubMed ID: 1168136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [10 years of L-DOPA therapy of Parkinson's syndrome].
    Birkmayer W
    Wien Klin Wochenschr; 1971 Apr; 83(13):221-7. PubMed ID: 4254333
    [No Abstract]   [Full Text] [Related]  

  • 44. L-DOPA: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice.
    Everett GM; Borcherding JW
    Science; 1970 May; 168(3933):847-50. PubMed ID: 5444060
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of L-DOPA on brain acetylcholine and choline in rats.
    Sethy VH; Van Woert MH
    Neuropharmacology; 1973 Jan; 12(1):27-31. PubMed ID: 4687273
    [No Abstract]   [Full Text] [Related]  

  • 46. End-product inhibition of tyrosine hydroxylase as a possible mechanism for regulation of norepinephrine synthesis.
    Spector S; Gordon R; Sjoerdsma A; Udenfriend S
    Mol Pharmacol; 1967 Nov; 3(6):549-55. PubMed ID: 6075244
    [No Abstract]   [Full Text] [Related]  

  • 47. On the behavioral and neurochemical actions of 6-hydroxydopa and 5,6-dihydroxytryptamine in rats.
    Richardson JS; Cowan N; Hartman R; Jacobowitz DM
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):29-44. PubMed ID: 4847904
    [No Abstract]   [Full Text] [Related]  

  • 48. Biochemical and behavioural alterations following 5,6-dihydroxytryptamine administration into brain.
    Breese GR; Cooper BR; Grant LD; Smith RD
    Neuropharmacology; 1974 Mar; 13(3):177-87. PubMed ID: 4407423
    [No Abstract]   [Full Text] [Related]  

  • 49. Production of ( 3 H)catecholamines in the brain following the peripheal administration of 3 H-dopa during pre- and postnatal development.
    Kellogg C; Lundborg P
    Brain Res; 1972 Jan; 36(2):333-42. PubMed ID: 5061894
    [No Abstract]   [Full Text] [Related]  

  • 50. Brain DOPA-5-HTP decarboxylase activity after the chronic administration of L-dopa or 5-hydroxy-L-tryptophan in normal and lesioned cats.
    Roberge AG; Poirier LJ
    Brain Res; 1974 Aug; 76(3):401-12. PubMed ID: 4546739
    [No Abstract]   [Full Text] [Related]  

  • 51. Norepinephrine and dopamine in the developing chick brain.
    Kobayashi K; Eiduson S
    Dev Psychobiol; 1970; 3(1):13-34. PubMed ID: 4146802
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monoamines in the rat brain.
    Roffler-Tarlov S; Schildkraut JJ; Draskoczy PR
    Biochem Pharmacol; 1973 Nov; 22(22):2923-6. PubMed ID: 4148604
    [No Abstract]   [Full Text] [Related]  

  • 53. On the localization of the hypotensive effect of L-dopa.
    Henning M; Rubenson A; Trolin G
    J Pharm Pharmacol; 1972 Jun; 24(6):447-51. PubMed ID: 4403826
    [No Abstract]   [Full Text] [Related]  

  • 54. [Comparison between the effect of L-dopa and its methylated ester on cerebral dopamine and noradrenaline of rats exposed to oxypertin].
    Van den Driessche J; Sado M; Linée P; Lacroix P; Le Clec'h G; Delamaire J; Patay M
    C R Seances Soc Biol Fil; 1973; 167(5):754-9. PubMed ID: 4799139
    [No Abstract]   [Full Text] [Related]  

  • 55. (S)-norepinephrine in the tissues of mice and rats given racemic erythro-3,4-dihydroxyphenylserine (DOPS).
    Porter CC; Torchiana ML; Stone CA
    Life Sci I; 1972 Aug; 11(16):787-95. PubMed ID: 4540250
    [No Abstract]   [Full Text] [Related]  

  • 56. L-dopa: disaggregation of brain polysomes and elevation of brain tryptophan.
    Weiss BF; Munro HN; Wurtman RJ
    Science; 1971 Aug; 173(3999):833-5. PubMed ID: 5572175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolism of norepinephrine, serotonin and dopamine in rat brain with stress.
    Bliss EL; Ailion J; Zwanziger J
    J Pharmacol Exp Ther; 1968 Nov; 164(1):122-34. PubMed ID: 4387046
    [No Abstract]   [Full Text] [Related]  

  • 58. Acute effects of 6-hydroxydopa on central monoaminergic neurons.
    Kostrzewa R; Jacobwitz D
    Eur J Pharmacol; 1973 Jan; 21(1):70-80. PubMed ID: 4709209
    [No Abstract]   [Full Text] [Related]  

  • 59. Social environment and brain biogenic amine metabolism in rats.
    Stolk JM; Conner RL; Barchas JD
    J Comp Physiol Psychol; 1974 Aug; 87(2):203-7. PubMed ID: 4279254
    [No Abstract]   [Full Text] [Related]  

  • 60. Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats.
    Schoenfeld RI; Uretsky NJ
    J Pharmacol Exp Ther; 1973 Sep; 186(3):616-24. PubMed ID: 4728340
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.